iBio Supporting AzarGen Biotechnologies’ Development of a Rituximab Biosimilar

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/11/2026

1. COO
2. ORCL
3. CHWY
4. ADBE
5. NVDA
6. AVAV
7. SPY
8. MSFT
9. META
10. ASO

Go back to iBio Supporting AzarGen Biotechnologies’ Development of a Rituximab Biosimilar
IBIO, Inc. (NASDAQ: IBIO) Delayed: 1.23 -0.03 (2.38%)
Previous Close $1.26    52 Week High $0.80 
Open $1.26    52 Week Low $0.34 
Day High $1.26    P/E N/A 
Day Low $1.22    EPS $-0.08 
Volume 309,019